Quality of Care

Response by Abdel-Qadir et al to Letter Regarding Article, “Bleeding and New Malignancy Diagnoses After Anticoagulation for Atrial Fibrillation: A Population-Based Cohort Study” Letter by Hu et al Regarding Article, “Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation” Cell-Free DNA Profiles End-Organ Injury and Predicts Outcomes in Advanced Heart Failure With Left Ventricular Assist Device Implantation Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Chronic Obstructive Pulmonary Disease and Asthma: Insights From ADAPTABLE Importance of Adherence Versus Intensification in Attaining Blood Pressure Control Geographic Disparities in Stroke Mortality: Many US States Unlikely to Meet National 2030 Target Improving Quality in Cardiac Arrest via Resuscitation Academy Training (IQ-CART): Study Protocol for a Mixed-Methods Study With a Focus on Low-Performing EMS Agencies Are We Too Lenient Toward ARBs? A Balanced Appraisal in Light of New Multidatabase Evidence Sex Differences in Atherosclerotic Coronary Artery Disease Patterns Letter by Kong and Wang Regarding Article, “Aspirin Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis Among Patients With Post-Thrombotic Syndrome: The Multicenter, Multinational, Randomized, Open-Label ARIVA Trial”